---
$id: https://graph.org.ai/products/commodity/51111704
$type: Product
source: UNSPSC
code: "51111704"
title: "Mitomycin"
class: "51111700"
classTitle: "Antineoplastic antibiotics"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Mitomycin

**UNSPSC Code**: 51111704
**Class**: [Antineoplastic antibiotics](Antineoplastic antibiotics.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an alkylating agent, antibiotics, antineoplastic, cross-linking reagent, and nucleic acid synthesis inhibitor with the molecular formula C15H18N4O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 50SG953SK6, chemically known as 6-amino-1,1a,2,8,8a,8b-hexahydro-8-(hydroxymethyl)-8a-methoxy-5-methylazirino(2,3:3,4)pyrrolo(1,2-a)indole-4,7-dione carbamate (ester) but generally known as mitomycin, which bears US NIH Compound Identifier 5746. European Medicines Agency schedules Mitomycin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09006MIG. The term MITOMYCIN is an International Non-Proprietary Name. World Health Organization schedules mitomycin in its Anatomical Therapeutic Chemical (ATC) Classification. MITOMYCIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule mitomycin under HS 29419000 and SITC 54139. As of Q4 2014, MITOMYCIN remains the US FDA Preferred Term for this commodity. Mitomycin bears US NLM identifiers UMLS ID C0002475 and NCI Concept Code C1820. SMILES: O(C12N(CC3NC13)C1=C(C2COC(=O)N)C(=O)C(=C(C1=O)C)N)C.

